Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implicationsA N Daud, A Ahsan, O Iqbal, et al.
Pulmonary Pharmacology & Therapeutics|August 10, 2000
Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosisD C Bode, E D Pagani, W R Cumiskey, et al.
Second Messengers and Phosphoproteins|January 1, 1990
Cellular distribution and pharmacological sensitivity of low Km cyclic nucleotide phosphodiesterase isozymes in human cardiac muscle from normal and cardiomyopathic subjectsP J Silver, P Allen, J H Etzler, et al.
Federation Proceedings|January 1, 1983
Phosphorylation of myosin light chain in skeletal and smooth musclesJ T Stull, P J Silver, J R Miller, et al.
European Journal of Pharmacology|July 22, 1998
Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5P J Silver, E D Pagani, R L Dundore, et al.
European Journal of Pharmacology|May 20, 1988
Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscleP J Silver, L T Hamel, M H Perrone, et al.
Cardiovascular Drugs and Therapy|October 1, 1989
Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agentsP J Silver, M J Connell, K M Dillon, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscleA L Harris, B M Lemp, R G Bentley, et al.
European Journal of Pharmacology|August 21, 1990
Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in ratsR L Dundore, P F Pratt, W D Hallenbeck, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanineP J Silver, B O'Connor, W R Cumiskey, et al.
Pageof 7